title: Imatinib (Gleevec) as a paradigm of targeted cancer therapies.
authors.affiliation: Department of Medicine, Oregon Health & Science University, Portland, Oregon 97239, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Druker
mesh_terms: D000970:Antineoplastic Agents / Q000266:history / Q000627:therapeutic use*; D001549:Benzamides; D035843:Biomedical Research / Q000266:history; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010879:Piperazines / Q000266:history / Q000627:therapeutic use*; D011743:Pyrimidines / Q000266:history / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate